MRK
Merck & Co., Inc.
NYSE · USHealthcareDrug Manufacturers - General
$124.41-2.42%
Price as of Jul 20, 2026
MRK valuation
Merck & Co., Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 13.78x
- P/E 2026E
- 24.30x
- P/E 2027E
- 12.86x
- P/E 2028E
- 11.61x
- P/S forward
- 4.49x
Trailing multiples
- P/E TTM
- 34.95x
- PEG TTM
- 0.23x
- Price / book
- 6.70x
- Price / sales
- 4.68x
- Price / cash flow
- 17.18x
Enterprise value
- Enterprise value
- $350.7B
- EV / sales
- 5.35x
- EV / EBITDA
- 18.68x
- EV / EBIT
- 19.38x
- Market cap
- $307.3B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.